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Development of human fetal kidney in obstructive uropathy: Correla-
tions with ultrasonography and urine biochemistry. In utero urethral
obstruction results in bilateral hydronephrosis and severe fetal and
post-natal morbidity and mortality. Obstetrical management depends on
the indirect evaluation of fetal renal function by ultrasonography and
biochemical analysis. No direct evaluation of the severity and possible
reversibility of renal lesions is available. In this paper we analyzed kidneys
from 34 fetuses (14 to 37 gestational weeks) in which (1) isolated bilateral
urinary tract obstruction had been detected in utero by sonography, and
(2) the severity of sonographic and biochemical prognostic indicators led
to the indication of termination of pregnancy or to perinatal death. Pure
hydronephrosis was observed in two young fetuses (14 and 20 gestational
weeks (GW)] and was associated with regressive changes in two others. In
contrast, a wide spectrum of dysplastic renal lesions was present in 30
fetuses and was classified into four subgroups according to the association
of dysplasia, hypoplasia and cysts. They had the following characteristics in
common: (I) premature cessation of nephrogenesis assessed by the
medullary ray counting method; (2) early disappearance or myofibroblas-
tic differentiation of metanephric blastema; (3) early increase in interstitial
mesenchyme with widespread expression of alpha-smooth muscle actin by
mesenchymal cells; (4) frequent absence of classical criteria of dysplasia
(nests of cartilage were observed in only 5 fetuses); (5) an identification,
based upon the detection of alpha-smooth muscle actin expression, of the
muscular phenotype of mesenchymal cells encircling primitive ducts. In
conclusion, (1) the value of prognostic markers in fetuses less than 20 OW
should be reconsidered; (2) after 20 GW there is a good correlation
between markers predicting poor prognosis and the severity of renal
lesions; (3) hypoplasia with disappearance of blastema cells, dysplasia and
early interstitial fibrosis are evidence of the irreversibility of renal lesions
and preclude any possibility of new nephron formation; (4) these findings
suggest that most surgical in utero procedures are performed when
irreversible renal lesions have developed.
Obstructive uropathy is a leading cause of renal failure in
childhood and adolescence. According to recent reports, it ac-
counts for 16.9% of renal transplantation at or before the age of
17 years [1] and is the leading cause of end-stage renal failure
(ESRF) occurring before the age of two years [2, 3].
Urinary tract malformations are now usually detected in utero
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by routine prenatal ultrasonography. Most are unilateral and have
a good functional prognosis provided the opposite kidney is
normal. In contrast, urethral obstruction, mostly due to urethral
valves in males, results in bilateral hydronephrosis and severe fetal
and postnatal morbidity and mortality. Death may be due to renal
dysplasia, or pulmonary hypoplasia if severe oligohydramnios
develops. About 50% of patients surviving the perinatal period
have or will develop renal failure [4, 5]. Obstetrical management
and prenatal counseling are difficult and depend on the evaluation
of fetal renal function and the prediction of postnatal outcome.
They are based on ultrasonographic evaluation of amniotic fluid
volume and renal parenchyma structure, and biochemical analysis
of fetal urine. Oligohydramnios, renal hyperechogenicity and
presence of cortical cysts on one hand, and high urinary sodium
and f32-mieroglobulin levels on the other, are considered to be
predictors of poor fetal or postnatal prognosis [6—14].
In fetal lambs, urinary obstruction produces hydronephrosis,
pulmonary hypoplasia and renal dysgenesis similar to that in the
humans, when ligation is performed during the first half of
gestation [15—20]. Decompression reverses the effect of experi-
mental obstruction, and at birth, residual renal damage depends
on the age at onset and the duration of obstruction [21, 22].These
promising experiments led to the development of in utero decom-
pression by shunting or open surgery in human fetuses [23—26].
Several groups have used this approach, but results are not as
good as initially expected. Fetal survival does not exceed 41%
[27], and the management of obstructive uropathy detected in
utero is still a matter of controversy [28, 29]. In some patients,
failure may be due to technical complications, but the main
problem remains the difficulty of accurately evaluating the severity
and possible reversibility of renal damage and the ability of the
developing kidney to produce new nephrons. Most fetal proce-
dures are probably performed when irreversible renal lesions have
developed.
To test the value of prognostic markers predicting perinatal
death and to evaluate the theoretical potential of post-decompres-
sion recovery, we analyzed by light and immunohistochemical
microscopy kidneys from 34 fetuses in which (1) isolated bilateral
dilation of the urinary tract due to obstructive uropathy was
detected in utero by sonography, and (2) the severity of prognostic
indicators led to indication of termination of pregnancy. Our aims
were: (i) to describe the renal lesions in the fetus in association
with urinary tract obstruction; (ii) to evaluate the degree of renal
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hypoplasia and examine the fate of metanephronic blastema; (iii)
to reconsider histological criteria of dysplasia in fetuses; and (iv)
to correlate renal lesions with ultrasonography and urine bio-
chemistry.
METHODS
Patients
Pregnant women were referred for bilateral dilation of the fetal
urinary tract related to lower urinary tract obstruction. All 34
patients underwent a level 3 ultrasound evaluation and fetal
karyotyping. On the basis of these investigations counseling was
offered by a materno-fetal medicine specialist. Two fetuses, 15
and 21 gestational weeks (GW) underwent vesicoamniotic shunt-
ing, which was not followed by urine production, and the preg-
nancies were terminated. On the whole, termination of pregnancy,
because of early onset, persistent and severe oligohydramnios
(N = 29) and/or ultrasonographic evidence suggestive of renal
dysplasia (N = 28), was considered in 30 cases, in accordance with
French legislation. In utero death occurred in one case. Three
fetuses who progressed to term died at birth. Fetal urinary
sampling was performed in 30 cases. According to previously
published data, sodium >70 mEq/liter and /32 microglobulin >10
mg/liter were considered as markers of ominous prognosis [12].
Fetuses presenting with chromosomal abnormalities or associated
malformations were excluded from the study.
Kidney specimens
Kidneys were obtained at the time of autopsy after termination
of pregnancy (N = 30) or spontaneous fetal or neonatal death
(N = 4). They were from 33 males and one female, gestational age
ranging from 14 to 37 GW counted from the last menstrual
period. All showed urethral obstruction and severe uretero-vesical
dilation due to abnormal posterior urethral valves (N = 13),
urethral atresia (N = 2), urethral stenosis or narrowing (N = 11),
polype (N = 1), or unidentified obstruction (N = 7). No ureteral
obstruction was associated with urethral obstruction. In 27 fe-
tuses, one or several features of the "Potter sequence" were
present, including pulmonary hypoplasia in 24.
Normal kidneys from 37 fetuses, 11 to 42 GW, obtained at
autopsy after spontaneous abortion or termination of pregnancy
for medical reasons, were used as controls.
Light microscopy: Quantitative analysis of nephrogenesis
Kidneys were fixed in 10% buffered formalin. Frontal cortico-
medullaiy sections taken through the hilus were embedded in
paraplast. Four-micrometer thick sections stained with trichrome-
light green, trichrome-safran or PAS were examined and com-
pared with age-paired controls obtained at autopsy after sponta-
neous abortion or termination of pregnancy for medical reasons.
Special attention was paid to blastema, hypoplasia, nephronic
origin of cysts and presence of dysplastic structures.
Renal hypoplasia means a reduction in the number of genera-
tions of nephrons. Its degree was evaluated by the "medullary ray
glomerular counting" method [30—321, on strictly corticomedul-
laiy sections taken through the hilus. Developing nephrons were
not considered. At least 6 medullary rays were counted in each
normal kidney. This number was increased in fetuses with urethral
obstruction when the degree of hypoplasia varied among reni-
cules. Dysplasia referred to abnormal spatial organization of
nephronic structures within the cortex, the medulla or both,
associated with abundance of interstitial mesenchyme and fre-
quently with cysts. The classical criteria of dysplasia, that is
cartilaginous metaplasia of the mesenchyme and typical primitive
ducts were frequently absent in fetal kidneys. Hypodysplasia
indicates the association of hypoplasia and dysplasia. Cysts with
diameter smaller than 0.5 mm were classified as microcysts.
Immunohistochemistry
Immunostainings were performed on formalin-fixed paraffin-
embedded tissues from 15 fetuses with urethral obstruction and
on 15 controls using the avidin-biotin method and the "Universal
Immunostaining Streptavidin-Peroxydase Kit" from Immunotech
(Marseille, France). Deparaffinized sections were rehydrated,
washed in PBS buffer for five minutes, treated five minutes by
H202 3% in methanol to block endogenous peroxidase activity
and washed in buffer for two minutes. Then, according to the
instructions of the manufacturer, they were sequentially incubated
for 10 minutes with the protein blocking agent and for 60 minutes
with the primary antibody (antibodies and corresponding dilu-
tions are indicated in the next section). After washing in PBS, the
sections were incubated for 30 minutes with the polyvalerit
secondary biotinylated antibody. Washed sections were incubated
for 45 minutes with streptavidin-peroxidase reagent. After wash-
ing, they were finally incubated for 10 to 20 minutes with the
freshly prepared chromogen solution [H202 and the chromogen
AEC (3-Amino-9 ethylcarbazole)I. Sections were counterstained
with hematoxylin and mounted in aqueous media. Control sec-
tions were processed as above but omitting the primary antibod-
ies.
Antibodies
Monoclonal anti-a smooth muscle actin was from Sigma Im-
munochemical (St. Louis, MO, USA), and lopath monoclonal
anti-epithelial membrane antigen (EMA, a marker for distal and
collecting tubules), anti-vimentin (V9) and anti-cytokeratin (KL1)
antibodies were from Immunotech. The monoclonal antibody
anti-CD 15 which recognizes an early myeloid differentiation
antigen and is a marker for proximal tubules was also from
Immunotech. Goat antiserum to Tamm-Horsfall protein (THP)
was purchased from Organon Teknika Corporation (Turnhoot,
Belgium). Rabbit anti-renin antibodies were a gift from P. Corvol
(INSERM U36, Paris, France). Their specificity has been previ-
ously established [33]. Antibodies were used at the following
concentration: keratin, epithelial membrane antigen (EMA) and
vimentin, pure (predilution was performed by the munufacturer);
CD15, 1/100; Tamm Horsfall glycoprotein, 1/100; a-smooth mus-
cle actin, 1/500; renin, 1/500.
RESULTS
Light microscopy: Classification of renal changes
By comparison with kidneys of age-paired controls, a wide
spectrum of renal lesions was observed. We classified them into 5
groups according to the presence and degree of hypoplasia and
dysplasia, and the presence, size and distribution of cysts. A
feature present in most cases was the increase in interstitial
mesenchyme and its dense organization around the dilated calyces.
Group I. Renal hypoplasia with dysplasia and microcysts: 19 cases
(Patients 1 to 19, 20 to 36 GW). In 19 cases, lesions were severe
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Fig. 1. Renal changes in obstructive uropathy. (A) Light microscopy, trichrome light green, fetal kidney [25 (GW)I. Preserved cortico-medullary
arrangement. Presence of cysts in the hypoplastic cortex. Marked dilatation of collecting ducts and abundance of mesenchyme in the medulla. (B) Light
microscopy, periodic acid Shift', fetal kidney (29 GW). Presence of large cysts surrounded by a thick collar of dense connective tissue. (C) Light
microscopy, trichrome light green, fetal kidney (21 GW); preserved cortico-medullary organization. Massive distribution of the cysts in the cortex. Poorly
developed medulla. (D) Light microscopy, periodic acid Shift, fetal kidney (24 GW). Large cortical cyst of glomerular origin as evidenced by the presence
of a shrunken glomerular tuft. (E) Light microscopy, triehrome light green, fetal kidney (26 GW). Architectural disorganization; cysts and clusters of
primitive duets are distributed within an abundant loose mesenchyme. (F) Anti-eytokeratin antibody, immunoperoxidase technique, fetal kidney (20
GW). Strong labeling of collecting duets. Preserved cortico-medullary organization. The papilla is flattened and collecting duets run in parallel with the
pelvic lumen (A X40; B X40; C x3; D X400; E and F X40). Publication of this figure in color is made possible by a grant from Immunotech Company,
Marseille, France.
and bilateral. Kidneys were small in size (compared with age- enchyme. Loops of Henle were scarce or absent. Severe regressive
paired normal kidneys) with a roughly preserved corticomedullary lesions characterized by glomerular sclerosis, tubular involution
arrangement. The cortex was hypoplastic and disorganized with or obstruction by hyaline casts, tubular basement membrane
irregular presence of microcysts (Fig. 1A). In the medulla the thickening and dense interstitial fibrosis were superimposed to
collecting duets were usually dilated, giving way to a delta-like developmental anomalies in three fetuses.
configuration. They were surrounded by an abundant loose mes- Renal lesions were symmetrical in 11 cases, whereas some
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variations in the degree of hypoplasia or the abundance of cysts
were observed in five fetuses. Three fetuses each had one kidney
with segmental hypodysplastic lesions; they alternated with a few
normal renicules or with renicules showing normal differentiation
of the deep cortex and cystic lesions of the outer cortex (type IV
dysplasia according to Potter [34]).
Group II. Total corticomedullaty dysplasia: 3 cases (Patients 20 to
22; 25 to 29 GW). In three cases, the normal kidney shape was
preserved but extreme renal dysplasia with poor corticomedullaiy
differentiation was observed. Cysts surrounded by a thick collar of
dense connective tissue were homogeneously distributed within
the cortex (Fig. 1B). The medulla was severely dysplastic with
presence of primitive ducts and abundant interstitial mesen-
chyme. The lesions were bilateral in one case. In two cases, lesions
of the controlateral kidney were similar to those described in
group I.
Group III. Bilateral cystic kidneys with medullaiy dysplasia: 5
cases (Patients 23 to 27; 21 to 32 GW). In five cases, both kidneys
had retained the corticomedullary differentiation but were greatly
enlarged by the presence of round cysts regularly distributed
within the whole cortex and surrounded by a thin basement
membrane (Fig. 1C). A collapsed capillary tuft was seen in some
cysts (Fig. 1D). Cysts were separated by an irregular network of
interstitial mesenchyme where some involutive nephronic struc-
tures were present. The medulla was poorly developed and
dysplastic.
Group IV Unilateral multi- or paucicystic kidney: 3 cases (Pa-
tients 28 to 30; 24 to 31 GW). In one case, one kidney was large and
grossly abnormal. It was made up of a bunch of irregular sized
cysts surrounding a central zone where a few dysplastic nephrons
could be seen (Fig. IE). In the two other cases only a large cystic
sac was present and a few involuted nephrons could be detected in
the cyst wall. The opposite kidney was hypoplastic and dysplastic
as in group I.
Group V: Hydronephrosis: 4 cases (Patients 31 to 34; 14 to 37
GW). Massive bilateral hydronephrosis, with normal corticomed-
ullary differentiation and normal cortex was observed in 3 cases
(14 to 23 GW). The medulla was flattened but had an otherwise
normal structure without dysplasia in the two youngest fetuses
(Fig. iF). In one neonate (GW37 H12), no dysplasia but severe
regressive changes of the parenchyma were superimposed to
hydronephrosis. In the medulla, papillary ducts ran in parallel
with and were separated from the pyelocalyceal epithelium by
massive accumulation of dense interstitial mesenchyme. Similar
but less severe papillary changes were observed in the 23 GW
fetus.
Quantitative study of nephrogenesis (glomerular counting)
Generations of developed glomeruli were counted in normal
kidneys from 37 fetuses 12 to 41 GW using the "medullary ray
glomerular counting" method. The number increased from one in
the 12 GW fetus (plus one developing nephron in the upper
cortex) to 8 to 9 at the end of gestation (Fig. 2). The same study
was performed on both kidneys of 29 fetuses with urethral
obstruction (Table 1 and Fig. 2). In severely dysplastic kidneys,
medullary rays could not be identified because of the disorgani-
zation of the cortex, and nephron counting was performed on
strictly orthogonal corticomedullary sections. No evaluation could
be performed on massively cystic kidneys (group III).
Comparison between age-paired kidneys showed a marked
reduction in the number of generations of nephrons in 22 of 29
cases (Table 1). This reduction was bilateral and homogeneous in
10 cases whereas it was unequal between kidneys or within the
same kidney in 12 cases (Fig. 2). No defect in nephrogenesis was
detected in fetuses with pure hydronephrosis (group V) or in the
3 youngest fetuses of group I (20 to 21 GW).
Metanephric blastema
In normal controls less than 34 GW, undifferentiated blastema
appeared as a continuous band of small cells located beneath the
capsule and surrounded by a loose extracellular matrix. Meta-
nephric blastema normally disappears at the end of the gestation.
The distribution and morphology of blastema cells were studied
in the 31 fetuses less than 34 GW with urethral obstruction (Table
1). Blastema was normal in the 3 fetuses 14 to 23 GW belonging
to group V (hydronephrosis). Normal blastema was only focally
found (in 10 to 50% of the subcapsular area) in 6 fetuses 20 to 29
GW and alternated with abnormal blastema in 2 of them.
Blastema was totally abnormal in 7 fetuses: blastema cells were
condensed, organized in parallel to the renal surface and packed
within a dense extracellular matrix. In the underlying cortex, a
reduced number of mature nephrons and no developing struc-
tures were observed (Fig. 3). The complete absence of blastema
was observed in 15 fetuses (20 to 34 GW).
Classical criteria of renal dysplasia
Nests of metaplastic cartilage located in the most superficial
cortex were found in five fetuses (cases 3, 14, 15, 16, 17) but were
abundant in only one case (case 16).
Medullary primitive ducts lined by a tall columnar epithelium
were observed in all cases except the four "group V" fetuses.
However, they were usually surrounded by collars of loose mes-
enchyme. Muscular differentiation of peritubular mesenchymal
cells was observed only in older fetuses.
Immunohistochemistry
Markers of tubular segments: CD15, Tamm-J-Iorsfall protein
(THP), epithclial membrane antigen (EMA). In normal fetal kid-
neys, CD15 was expressed in the proximal part of the nephron
from the glomerular capillary loop stage. THP was colocalized
with EMA in the ascending ioop of Henle and the distal tubule,
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Fig. 2. Quantitative study of nephrogenesis in normal fetuses (+) and in
fetuses with urethral obstruction (o). The number of generations of
glomeruli increases in normal fetuses from 1 at 12 gestational weeks (GW)
to 9 at the end of the gestation.
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Table 1. Characteristics of the 34 fetuses with urethral obstruction
Age at
diagnosis
Amniotic
fluid US
Urine biochemistry Morphological study
Site of Na f32M Age Blastema Generations
Patients GW volume Dysplasia sampling mEqlliter mg/liter GW % of glomeruli
ia 15 50 ? 20 — 2—4
2 19 SO + B 113 4.2 20 — 2—3
3 21 SO + B 87 9.4 21 50 1—5
4 21 50 + B 111 20.4 22 — 2—3
5 22 SO + B 132 15.4 22.5 — 1—3
6 22 P + L
B
77
83
4.2
4.3
23 30 1—6
7 23 SO + B 117 35 23 — 2—5
8 21 50 + B 96 11 23 — 1—3
9 19 50 + B 119 25.5 — 3
10 24.5 50 + B 129 20 25.7 — 1—3
11 27 SO ? B 133 12.8 27 — 1-2
12 25.5 50 + R 75 17 27.5 10 1—4
13 25 N + B 75 4.7 28 20 1—7
14 26 N + R
L
B
79
82
79
11.1
10.8
10.7
29 10 1—3
15 32 SO thin L
B
83
88
42
40
33 — 1—7
16 31 SO thin 33 — 1—3
17 33 SO + B 91 7 34 — 2—5
18 30 SO + R
L
B
52
130
63
7.3
7.5
8.4
36.5 (D) ND 3—4
19 34 50 + R
L
B
52
71
53
7.8
8.8
36 (D) ND 3—7
20 26 SO + L 140 18 26 — 1—5
21 23 N + B 94 14.3 29 — 0—5
22 28 SO + L 138 16 29 — 0—3
23 21 SO + B 135 13 21 — ND
24 21 SO + R
L
B
138
130
136
23
22
23
22 — ND
25 24 SO + B 133 35 24 — ND
26 26 SO + B 120 12 26 — ND
27 32 SO + B 111 12 32(D) — ND
28 23.5 SO + 24 25% 0—5
29 21 SO + R
L
127
84
7
6
26 50% 0—7
30 31 SO + B 135 20 31 1—2
31 14 0 ? B 123 8 14 100% 2
32 19 SO thin 20 100% 3—4
33 19 P ? B 112 4.7 23 100% 5—6
34 34 SO thin L
B
61
108
3
6
37 (D) ND 5—8
The table is divided in 5 parts corresponding to the 5 groups of histological lesions. Abbreviations are: GW, gestational weeks; US, ultrasonography;
0, oligohydramnios; SO, severe oligohydramnios; P, polyhydramnios; Na, sodium (normal value <50 mmol/liter); J32m, /32-microglobulin (normal value
<2 mg/liter); B, bladder; R, right pelvis; L, left pelvis; N, normal; D, perinatal death; Blastema %, percentage of the subcapsular cortex showing normal
blastema; ND, not determined.
Fetuses who underwent urinary decompression
whereas only EMA was expressed by the collecting duct cells. The cysts were inconstantly labeled with anti-CD 15 antibodies. Large
Bowman capsule was unstained with the different antibodies cortical cysts usually remained unlabeled or expressed very focally
except for infrequent labeling of some cells with the anti-CD15 CD15 (Fig. 4A). Urinary casts containing THP were observed in
antibody. half of the fetuses. They were present in the distal part of the
In kidneys from fetuses with urethral obstruction, the same nephrons, in the Bowman space and in dilated structures (Fig.
distribution was observed in normal structures. Cortical micro- 4B). In addition, interstitial TPH aggregates were found in seven
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Fig. 3. Renal changes in obstructive uropathy. Light microscopy, peri-
odic acid Shiff, fetal kidney [23 gestational weeks (GW)]. Note the
abnormal blastema characterized by the condensation of blastema cells
within a dense extracellular matrix (X250).
cases. The abundance of THP deposits increased with fetus age.
EMA-positive cortical collecting ducts were normally observed in
group V. A few sections of EMA-positive ducts were focally seen
between cysts up to the superficial cortex in group III. Cortical
collecting ducts were present but frequently distorted in group I
(Fig. 4C). Medullary cysts and primitive ducts were EMA positive
(Fig. 4D) and usually THP-negative.
Intermediate filaments: Cytokeratin and vimentin. In normal
fetuses cytokeratin was expressed by epithelial cells except podo-
cytes from the initial step of nephron differentiation. The expres-
sion was strongest in the collecting ducts. Vimentin was expressed
faintly by the undifferentiated blastema and mesenchymal cells
and strongly by the podocytes (not shown).
In the obstructive uropathy group, small cortical cysts lined by
a tall epithelium normally expressed cytokeratin. Expression was
very faint and inconstant in large cortical cysts lined by a flat
epithelium. It was strong in medullary cysts. Focal expression of
vimentin was observed in some cyst lining cells (not shown).
Alpha-smooth muscle actin (a-SM actin). In normal fetal kid-
neys, a-SM actin was strongly expressed by vascular smooth
muscle cells (Fig. 5A). No expression was detected in interstitial
or blastema cells whereas occasional expression could be seen in
a few glomerular mesangial cells (Fig. 5A). The interstitial cells of
the medulla were negative even at the tip of the papillae. In
contrast, smooth muscle cells in the calyx wall are a-SM actin-
positive (Fig. 5B).
In addition to the normal vascular and mesangial distribution,
widespread expression of a-SM actin was observed in fetal
kidneys upstream of urethral obstruction. In the cortex, a-SM
actin was seen in abnormally condensed blastema cells (Fig. 6A)
and in the abundant mesenchyme surrounding developing and
mature nephrons (Fig. 6 A, B). In the medulla, strong expression
of a-SM actin was seen in mesenchymal cells surrounding primi-
tive ducts from the age of 21 GW even when the myofibroblastic
phenotype could not be recognized by classical light microscopy
(Fig. 6C). Labeling was negative or moderate (Fig. 6D) in the
loose mesenchyme at a distance from epithelial structures. In the
papillae, the condensed mesenchyme beneath the epithelium of
dilated calyces strongly expressed a-SM actin (Fig. 7E). No
expression of a-SM actin was detected in tubular epithelial cells.
Renin. The distribution of renin was studied in 21 normal fetal
kidneys. In 18, a few cells in 10% or less of the juxtaglomerular
apparatus (JGA) were renin-positive whereas renin labeling was
observed in 10 to 20% of MG in 3 fetuses. Focal labeling of
interlobular (in youngest fetuses) or preglomerular arteries could
also be focally observed. Renin distribution was studied in 21
fetuses with obstructive uropathy. In 16, less than 10% of AJG
were labeled. Ten to 20% of JGA were renin-positive in 4 fetuses
belonging to group III (case 25), IV (case 26 in the kidney
opposite to the multicystic one) and V (cases 32 to 33). In patient
34, presenting with hydronephrosis and severe regressive changes,
about 50% of JGA were positive (Fig. 7). Statistical analysis using
the "Armitage Test for Trends in Proportions" did not show any
significant differences between the two groups.
Correlations of renal lesions with ultrasonography and fetal
urine biochemistry
We analyzed separately the 29 fetuses with severe oligohy-
draminos and the 5 with normal or increased amniotic fluid.
Twenty-nine fetuses (F ito 5, 7 to 12, 15 to 20, 22 to 32, 34) had
persistent and severe oligohydramnios which was not improved in
the two who underwent urinary decompression (Table 1). Twenty-
two of them had ultrasound evidence of renal dysplasia charac-
terized by loss of corticomedullary differentiation, renal hypere-
chogenicity and presence of renal cortical cysts. In 3 fetuses,
kidneys could not be seen because of the severity of urinary tract
dilation (N = 2) or the very young age at examination (N = 1).
Marked reduction in parenchymal thickness was observed in 4
fetuses. Urine biochemistry performed in 25 of 29 fetuses showed
abnormal values of sodium and/or 132 microglobulin in 21 of them
(Table 1). On the basis of radiological and biochemical findings
predictive of a severe perinatal outcome, pregnancy was termi-
nated in 25 cases. In addition fetus 27 died in utero. Fetuses 18,
with asymmetric renal repercussion and fetuses 19 and 34 whose
urine biochemistry was less severely modified, progressed to term
but died soon after birth from pulmonary hypoplasia. Analysis of
kidney lesions in the 29 fetuses showed severe hypoplasia and
dysplasia, with complete or nearly complete disappearance of
normal blastema in 24. Hypodysplasia was moderate and irregu-
larly distributed but associated with severe regressive changes of
the parenchyma in 2 fetuses (fetuses 18 and 19). In fetus 34,
hydronephrosis was associated with prominent regressive changes.
Two fetuses of 14 and 20 GW (fetuses 31 to 32) had pure
hydronephrosis.
Amniotic fluid volume was normal (N = 3) or increased (N =
2) in five fetuses (fetuses 6, 13 to 14, 21, 33). However, ultrasound
examination demonstrated renal dysplasia and fetal urine analysis
showed abnormal levels of sodium and/or 132 microglobulin in all
of them. Pregnancy was terminated in all five cases. Severe
bilateral hypodysplasia was found in two fetuses (fetuses 14 and
21). Hypoplasia was asymmetric in two fetuses (fetuses 6 and 13)
with irregular alternation of normal and severely dysplastic reni-
cules in one of the kidneys, the other being hypodysplastic.
Hydronephrosis without hypodysplasia but with severe interstitial
fibrosis was observed in fetus 33.
In this group of fetuses with severe urethral obstruction, no
correlation was observed between the age at renal examination
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Fig. 4. Renal changes in obstructive uropathy. Immunoperoxidasc microscopy. (4) Fetal kidney [20 gestational weeks (GW)1 stained with anti-CD 15
antibody. Negative (double arrow) or very focal staining (arrow) of large cortical cysts. (B) Fetal kidney (27 GW) stained with anti-THP antibodies.
Accumulation of THP in tubules (arrow) and Bowman spaces (double arrow). Presence of an interstitial THP aggregate (head arrow). (C) Fetal kidney
(23 OW) stained with anti-EMA antibody. Positive labeling of longitudinal (arrow) and transversal (double arrow) sections of cortical collecting tubules.
(D) Fetal kidney (25 OW) stained with anti-EMA antibody. Dysplastic medulla. Positive staining of the apical membrane of primitive duct epithelial
cells (A x50; B ><310; C x170; D X350).
and the type or severity of renal lesions. For example, fetuses 1 cystic kidneys with medullary dysplasia). It was characterized by
and 2 (20 GW) had diffuse dysplasia with total disappearance of the association of large hyperechogenic kidneys at sonography
blastema cells, whereas fetuses 31 and 32 (14 and 20 GW) had and major changes in fetal urine biochemistry with sodium value
pure hydronephrosis. Interestingly, homogeneous presentation greater than 110 mEq/liter and f32 microblobulin level greater
was observed in the five patients belonging to group III (bilateral than 10 mg/liter.
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Fig. 5. Normal fetal kidney. Immunoperoxidase microscopy, fetal kidney
[22, 5 gestational weeks (GW)] stained with anti-alpha smooth muscle
actin antibody. (4) Sharp staining of artery smooth muscle cells and
irregular labeling of glomerular mesangial cells. Negative labeling of
interstitial cells. (B) Negative labeling of papillary mesenchymal cells
(arrow). Positive staining of smooth muscle cells in the pelvic wall (double
arrow) (A X90; B X250).
DISCUSSION
In the present study, we analyzed by light microscopy and
immunohistochemistry the renal changes developed in association
with urethral obstruction in 34 fetuses, 14 to 36 GW, considered
as having a poor perinatal prognosis on ultrasonography and fetal
urinary biochemistry. The renal lesions ranged from pure hydro-
nephrosis to severe and diffuse hypodysplasia with the presence of
various sized cysts, in some cases mimicking polycystic disease.
Type IV dysplasia, a less severe renal change characterized by
conservation of normal renal structure and presence of subcap-
sular cysts, and described by Osathanondh and Potter [341 as due
to urethral obstruction, was observed in only one of the two
kidneys of three fetuses.
The pathogenesis of hypodysplasia associated with urethral
obstruction is controversial. It could result from an overall
developmental defect of the reno-urinary system, abnormal induc-
tion of abnormal renal blastema by the ectopic ureteric bud
leading to dysplasia [35]. Another hypothesis is that hypodysplasia
develops as a direct consequence of obstruction. Given the
therapeutic implications, resolution of this issue is of importance.
Several morphologic features, such as the delta-like configuration
of the medullaty collecting system in young fetuses, the presence
of organized and myofibroblast-rich fibrosis encircling the dilated
calicae and progressing with fetal age, and the accumulation of
Tamm-Horsfall protein not only in distal tubules but also in
proximal parts of the nephron suggest that abnormal urodynamics
is implicated early in the development of renal changes referred to
as obstructive nephropathy. In animal models, back pressure also
induces renin-angiotensin dependent hemodynamic changes that
participate in renal impairment and are not completely reversed if
relief of obstruction is delayed [36—38]. In our series of fetuses
with urethral obstruction, increased expression of renin was not
commonly observed, perhaps because of the long duration of
obstruction leading to permanent dysplastic changes at the time of
examination. The mechanism of renal dysplasia itself cannot be
deduced from morphologic findings in human fetuses. However,
experimental models of early urinary tract obstruction in the fetal
lamb provide clear evidence of the noxious effect of obstruction
on fetal kidney development eventually leading to true dysplasia
[15—201. It is now recognized that urethral obstruction per se is
either entirely responsible for or at least participates in the
constitution of renal lesions. This observation is the basis for in
utero vesicoamniotic derivation [21—261.
Two methods based on quantification of glomeruli have been
proposed to evaluate nephrogenesis and hypoplasia on kidney
tissue sections. In that described by Gasser et al, the total number
of glomeruli is determined on whole longitudinal frontal sections
taken through the hilus [39]. In normal fetal kidneys, this number
increases between 10 and 36 GW. In obstructive uropathies, the
number of glomeruli is lower. By comparison with normal con-
trols, it can be correlated to the time of cessation of nephron
formation and could therefore indicate the onset of renal impair-
ment due to urinary obstruction [39]. The second method, "med-
ullary ray glomerular counting," consists of quantifying the num-
ber of layers of glomeruli along the bundles of collecting ducts in
the cortex, between the capsule and the cortico-medullary junc-
tion [30—321. Because asymmetric and/or unequal intrarenal
repercussion of urethral obstruction was observed in numerous
fetuses, we chose the second method as more appropriate to
detect initial impairment in nephrogenesis. We compared the
findings with those obtained in a series of 37 normal kidneys from
12 to 40 GW fetuses. Reduced nephrogenesis was obvious in all
fetuses of more than 20 GW, except those with pure hydrone-
phrosis. It was diffuse and homogeneous in half of them, whereas
in others a striking heterogeneity was observed with some reni-
cules showing normal development and most others being hypo-
plastic. Regarding the most hypoplastic renicules, only one or two
layers of glomeruli were present, indicating that the renal reper-
cussions of obstruction with the arrest of nephrogenesis usually
began before 20 GW.
During human renal development, nephrogenesis is a continu-
ous process between the 8th and 34th GW. It results from ureteric
bud-induced conversion of metanephric blastema to epithelium.
Therefore, the ability of the developing kidney to produce new
nephrons is dependent on both the presence of normal undiffer-
entiated blastema and of normal ampullary bud induction. Ab-
sence or very focal persistence of blastema was observed in most
fetuses whatever their age. The mechanism leading to the early
and abnormal disappearance of metanephric blastema has not
been elucidated. However, Gasser et al [40] recently showed an
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Fig. 6. Renal changes in obstructive uropathy. Immunoperoxidase
microscopy, anti-alpha smooth muscle actin antibody. (A) Fetal kidney (26
GW). Strong positive staining of blastema (arrow) and irregular staining
of cortical interstitial cells. (B) Fetal kidney (34 GW). Positive staining of
cortical mesenchymal cells surrounding nephronic structures and cysts.
(C) Fetal kidney (22 GW). Positive staining of mesenchymal cells sur-
rounding primitive ducts (arrow) and negative labeling of the loose
interstitial mesenchyme. (D) Fetal kidney (23 GW). Strong and diffuse
staining of mcsenchymal cells densely packed around primitive ducts or
forming the loose interstitium. (E) Fetal kidney (GW). Marked staining of
mesenchymal cells arranged around the dilated calyx (A and B >< 60; C-E
x150).
increased number of apoptotic blastema cells in fetuses with hand, defects in ampullary bud branching or abnormalities in
obstructive uropathies. Here we describe another pattern of ampullary bud cells, as suggested by the reduced number or the
abnormal evolution of blastema cells, that is, an abrupt differen- distortion of EMA-positive cortical collecting ducts, may also be
tiation into myofibroblastic cells, as evidenced by the aberrant implicated in the genesis of hypoplasia and dysplasia.
expression of ts-SM actin. This abnormal commitment is associ- Renal maldevelopment was observed in all fetuses except those
ated with a strong expression of interstitial extracellular matrix with pure hydronephrosis. It was characterized by architectural
proteins, tenascin and types III, V and VI collagen [411. On the disorganization, presence of dysmorphic glomeruli, cysts and
whole, early disappearance or abnormal myofibroblastic differen- poorly differentiated cortical tubules, paucity in medullary tubules
tiation of metanephric blastema accounts for hypoplasia and and abundance of interstitial mesenchyme. However, renal struc-
precludes any possibility of new nephron formation. On the other tures regarded as obligatory criteria for renal dysplasia were not
I?
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Fig. 7. Renal changes in obstructive uropathy. Immunoperoxidase mi-
croscopy, anti-renin antibody. Fetal kidney (37 GW). Staining of numer-
ous juxtaglomerular apparatuses (arrow) and of arteriolar smooth muscle
cells (double arrow) (X 120).
present in all of these maldeveloped kidneys. A small number of
cartilage nests were seen in only 5 of 34 fetuses. They were absent
in the younger ones, suggesting that this abnormal differentiation
of metanephric blastema occurs at a late stage of kidney devel-
opment. Primitive ducts in the medulla are usually described as
lined by tall columnar epithelium and surrounded by a fibromus-
cular collar [42]. They were observed in most cases of urethral
obstruction, but in younger fetuses, presumed primitive ducts
were surrounded by a loose interstitial mesenchyme and the
fibromuscular phenotype could only be demonstrated by immu-
nohistochemical detection of cellular a-SM actin expression.
The origin of cortical and medullaiy cysts was assessed using
antibodies specific for the different tubular segments. In the
cortex, microcysts were frequently labeled with the CD15 anti-
body, a proximal tubule marker. In large cysts lined by a flat
epithelium, a glomerular origin could be suggested on the pres-
ence of a shrunken glomerular tuft and negative staining with the
series of antibodies used, except for inconstant and segmental
labeling with the CD15 antibody. Medullary cysts positively
labeled with the anti-EMA antibody and negative for CDI5 and
the Tamm-Horsfall protein were developed from the collecting
ducts.
It is now accepted that interstitial fibrosis plays a major role in
the progression of every type of renal damage [43]. In human
hydronephrotic kidney, interstitial fibrosis is correlated with tu-
bular lesions [44]. Fibrosis develops rapidly after ureteral ligation
in the adult rabbit model of obstructive nephropathy [45]. Several
features support the role of renal interstitial myofibroblasts in the
multistep cellular and molecular cascade ultimately leading to
fibrosis. Phenotypic modulation of interstitial cells into activated
myofibroblasts expressing a-SM actin is associated with progres-
sive fibrosis in a wide range of wounds [46]. In the kidney,
myofibroblasts observed during experimental and clinical ne-
phropathies have a strong predictive value for the development of
fibrosis [47, 48]. Up-regulation of a-SM actin has been demon-
strated after unilateral ureteral obstruction, a model of progres-
sive interstitial scarring in the adult rat [49]. Administration of
angiotensin II or PDGF-BB induces renal tubulointerstitial myo-
fibroblast formation and is accompanied by interstitial fibrosis and
increased expression of type III collagen [50, 51]. In the human
fetal kidney with urethral obstruction, we show that both in-
creased interstitial mesenchyme and inappropriate a-SM actin
expression occurred as early as 20 GW. Myofibroblast phenotype
was observed not only in blastema cells as previously discussed,
but also in cortical interstitial cells, in cells surrounding primitive
ducts or encircling dilated calyces and frequently in medullary
interstitial cells. These findings indicate clearly that in addition to
developmental defects, urinary outlet obstruction triggers an
aberrant differentiation of the interstitial mesenchyme, eventually
leading to fibrosis and progressive renal failure. Another mecha-
nism possibly implicated in the progressive destruction of dysplas-
tic kidneys is apoptosis, since recently Winyard et a! demonstrated
an increased incidence of apoptosis in dysplastic human kidneys
[52].
Overall, renal repercussion of obstruction was severe in 32 of 34
fetuses, confirming the value of prognostic indicators that led to
termination of pregnancy or perinatal death [7—141. No correla-
tion was found between the severity of renal changes and the
gestational age; dysplasia and disappearance of blastema were
seen as early as 15 GW. One emerging problem was the difficulty
of assessing renal function and prognosis in young fetuses with
obstructive uropathy at a time when urinary derivation is difficult,
but could possibly prevent the development of renal lesions. Two
young fetuses (14 and 20 GW) with early oligohydramnios and
indicators of severe renal dysfunction at birth, had only pure
hydronephrosis. On the other hand, one fetus who underwent
effective urine derivation at 15.5 GW because of oligohydramnios,
dilation of the urinary system and nonvisualization of the renal
parenchyma, and who did not recover, had bilateral and severe
cystic dysplasia at 20 GW. It is possible but not yet demonstrated
that evaluation of fetal serum 132 microglobulin, which reflects
fetal glomerular filtration, could be helpful in these particular
conditions [52]. It has not yet been elucidated why most fetuses
with severe urethral obstruction and high intrapelvic pressure
develop hypodysplasia, whereas others belonging to the same age
group have hydronephrosis eventually associated with regressive
changes. No difference in clinical presentation, sonographic or
biochemical findings, or urethral lesions could be identified.
Differences in the architecture or the maturation of renal papillae
[53] (a hypothesis not investigated in this study) could explain
different modes of evolution of renal lesions, with fetuses having
non-refluxing papillae developing hydronephrosis, and those with
intrarenal reflux developing hypodysplasia.
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